Cardiovascular-kidney-metabolic stage progression
Cardiovascular-kidney-metabolic stage progression has been studied in 1 paper since 2026: 1 observational study in people; 1 in the past year. The newest paper, Jun 12, 2026: “Stage-Specific Progression of Cardiovascular-Kidney-Metabolic Health and Mortality in a Nationwide Cohort of East Asian Adults”.
1 paper studies it1 findingUpdated
See all 1 papers on cardiovascular-kidney-metabolic stage progression
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“CKM stage progress was significantly associated with a higher risk of all-cause mortality (adjusted hazard ratio [HR], 1.38 [1.36 to 1.41])”
- 1 lab in 1 country
- Funders: Korea Health Industry Development Institute and 2 more
- Humans1
What is cardiovascular-kidney-metabolic stage progression linked with?
1Studies link cardiovascular-kidney-metabolic stage progression with 1 measure, most often mortality (1 study).
Mortality
upin humans1
1 study
Mortality
upin humans1
Cardiovascular-kidney-metabolic stage progression is linked with a higher risk of mortality in humans (adjusted for clinicodemographic variables).
“CKM stage progress was significantly associated with a higher risk of all-cause mortality (adjusted hazard ratio [HR], 1.38 [1.36 to 1.41])”
Humansadjusted for clinicodemographic variables6.4-year follow-up
Clinical journal of the American Society of Nephrology : CJASN